Prime Medicine, Inc. PRME
3.95 USD +0.11 (+2.86%)
As ofNov 18, 2026, 10:42 AM EST
3.76 Day range 4.28
2.67 52-week range 5.91
- YTD
- +13.83%
- 1 year
- +11.27%
News
seekingalpha.com Prime Medicine, Inc. (PRME) Presents at Jefferies Global Healthcare Conference 2026 Transcript Prime Medicine, Inc. ( PRME ) Jefferies Global Healthcare Conference 2026 November 16, 2026 11:00 AM EST Company Participants Allan Reine - CEO & Director Conference Call Participants Maurice…benzinga.com HC Wainwright & Co. Reiterates Buy on Prime Medicine, Maintains $8 Price Target HC Wainwright & Co. analyst Arthur He reiterates Prime Medicine (NASDAQ:PRME) with a Buy and maintains $8 price target.
zacks.com Prime Medicine, Inc. (PRME) Reports Q3 Loss, Lags Revenue Estimates Prime Medicine, Inc. (PRME) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.32 per share a year ago.benzinga.com Prime Medicine Q3 EPS $(0.22) Beats $(0.25) Estimate, Sales $4.213M Beat $1.206M Estimate Prime Medicine (NASDAQ:PRME) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.25) by 12 percent. This is a 31.25 percent increase over losses of $(0.32)…
globenewswire.com Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares CAMBRIDGE, Mass., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic…
globenewswire.com Prime Medicine Reports Third Quarter 2026 Financial Results and Provides Business Updates -- First patient dosed in global Phase 1/2 clinical trial of PM577a in Wilson disease, the first clinical study of an in vivo Prime Editing therapy from Prime Medicine; initial clinical data expected…
247wallst.com Cathie Wood Dumps the Last of Teradyne From Her Flagship Fund ARK's flagship fund exited a chip-testing stock just as it surged on a fresh Buy rating, and Wood offered no explanation. Another ARK fund still holds millions in shares, so the real question is what…benzinga.com Prime Medicine Commences $125M Offering Of Common Shares Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that it has commenced an…
